Table 3.

Relationship between PARP1 cleaved and non-cleaved with clinicopathological parameters

Variables	PARP1 non-cleaved			PARP1 cleaved
	Negative n (%)	Positive n (%)	p value	Negative n (%)	Positive n (%)	p value
Menopausal status
Pre	182 (33.2)	216 (41.7)	0.004	65 (33.5)	409 (38.5)	NS
Post	366 (66.8)	302 (58.3)		129 (66.5)	653 (61.5)
Age
<50	163 (29.7)	193 (36.9)	0.012	61 (31.4)	365 (34)	NS
≥50	386 (70.3)	330 (63.1)		133 (68.6)	710 (66)
Tumour size
≤2 cm	279 (51.2)	240 (46.1)	NS	96 (50)	523 (48.8)	NS
>2 cm	266 (48.8)	281 (53.9)		96 (50)	548 (51.2)
Tumour stage
1	346 (62.9)	310 (59.5)	NS	129 (66.5)	634 (59.2)	NS
2	159 (28.9)	164 (31.5)		51 (26.3)	342 (31.9)
3	45 (8.2)	47 (9.0)		14 (7.2)	95 (8.9)
Tumour grade
1	113 (20.7)	69 (13.3)	0.001	32 (16.7)	180 (17.9)	NS
2	180 (33)	163 (31.3)		61 (31.8)	368 (34.5)
3	253 (46.3)	288 (55.4)		99 (51.6)	519 (48.6)
Tubule formation
1	35 (6.7)	24 (4.7)	NS	11 (5.9)	62 (6)	NS
2	181 (34.6)	160 (31.6)		57 (30.3)	336 (32.6)
3	307 (58.7)	323 (63.7)		120 (63.8)	634 (61.4)
Pleomorphism
1	14 (2.7)	10 (2)	<0.001	1 (0.5)	29 (2.8)	NS
2	233 (44.6)	168 (33.1)		76 (40.4)	404 (39.2)
3	275 (52.7)	329 (64.9)		111 (59)	598 (58)
Mitosis
1	201 (38.4)	145 (28.6)	0.001	66 (35.1)	373 (36.1)	NS
2	103 (19.7)	95 (18.7)		30 (16)	200 (19.4)
3	219 (41.9)	267 (52.7)		92 (48.9)	459 (44.5)
Vascular invasion
Negative	185 (34)	174 (33.5)	NS	65 (34)	355 (33.2)	NS
Positive	359 (66)	346 (66.5)		126 (66)	714 (66.8)
NPI groups
Good	190 (34.9)	134 (25.7)	0.005	63 (32.8)	326 (30.4)	NS
Moderate	269 (49.4)	295 (56.6)		94 (49)	566 (52.8)
Poor	86 (15.8)	92 (17.7)		35 (18.2)	179 (16.7)

Bold values indicate significance

NS not significant